VRSK Verisk Analytics Inc

Verisk Enters Egypt Health Insurance Market Through AXA Deal

Verisk Enters Egypt Health Insurance Market Through AXA Deal

AXA selects Verisk’s Health Risk Rating Tool and Ratings Engine to assess substandard risks posed by pre-existing medical conditions

CAIRO, Egypt, Aug. 28, 2023 (GLOBE NEWSWIRE) -- AXA Life & Health Reinsurance Solutions has selected Verisk’s Health Risk Rating Tool and Ratings Engine to help its insurance partners in Egypt automate health insurance underwriting based on the declared pre-existing medical conditions of their customers. This deal marks the first time Verisk, a global data analytics and technology provider for insurers, provides a product or service to Egypt’s insurance market.

Verisk’s Health Risk Rating Tool, which will be marketed as AXA’s Intelligent Medical Acceptance Tool (IMPACT), enables insurers to grow by helping them make more informed underwriting decisions at point of sale. The solution analyses an applicant’s responses to a dynamic question set, assesses the applicant’s pre-existing medical conditions, and generates risk scores that insurers can use to better understand the cost of maintaining a condition and any potential complications.

Verisk’s Health Risk Ratings Engine is an additional module of the solution that streamlines the process by allowing insurers to configure their own rules based on the risk scores and generate real-time automated underwriting decisions.

“The new Ratings Engine feature of the Health Risk Rating Tool has vastly improved IMPACT’s accessibility and efficiency in providing bespoke health insurance products to a wider demographic of customers,” said Laurent Pochat-Cottilloux, CEO of AXA Life & Health Reinsurance Solutions. “Customers with pre-existing medical conditions should now have a much better experience finding cover that suits them.”

This deal builds on an existing business relationship between Verisk and AXA Life & Health Reinsurance, with AXA using Verisk’s Health Risk Rating Tool in China, Vietnam and the Philippines.

“Our entry into Egypt’s health market is not only a significant achievement in expanding our global presence in EMEA but it is also a positive step forward in our ongoing relationship with AXA,” said Rachel Edwards, Managing Director of Verisk Life, Health & Travel. “The addition of the Ratings Engine to our product suite has expanded the value Verisk can add to our customers’ underwriting process and has greatly assisted AXA’s launch in Egypt.”

The Health Risk Rating Tool is available as a standalone portal or as an integrated API. For more information, e-mail .

Verisk's Life, Health & Travel business has worked with insurers to automate the assessment of pre-existing conditions with the Risk Rating Tool since 2000. The integration of Verisk's software into the workflows of insurers, brokers, distributors, banks and price comparison websites has established the Risk Rating Tool as a leading solution in the marketplace.

About Verisk 

Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, ESG and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by  and fosters an  where all team members feel they belong. For more, visit  and the . 



Media Contact
Mary Keller
Verisk
(339) 832-7048
 
EN
28/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Verisk Analytics Inc

 PRESS RELEASE

Verisk Reiterates its Growth Targets and Outlines Strategy for its Nex...

Verisk Reiterates its Growth Targets and Outlines Strategy for its Next Phase of Compounding Growth at 2026 Investor Day JERSEY CITY, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will host its Investor Day today at 8 a.m. ET, where Verisk President and CEO Lee Shavel, CFO Elizabeth Mann and members of the company’s senior leadership team will outline the company’s strategy, competitive positioning and financial framework designed to deliver durable, compounding growth and strong ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 28, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Verisk Analytics Inc: 3 directors

Three Directors at Verisk Analytics Inc bought 2,500 shares at between 179.200USD and 180.160USD. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch